N06DA Anticholinesterase anti-dementia drugs
ATC group of level 4 – chemical subgroup · in plain English: medicines for dementia, e.g. Alzheimer's disease
This site has the patient leaflet or the SPC of 128 medicines in this group and its subgroups.
Place in the ATC classification
- N Nervous system drugs 4,479 medicines
- N06 Psychoanaleptics 766 medicines
- N06D Anti-dementia drugs 193 medicines
-
N06DA Anticholinesterase anti-dementia drugs 128 medicines
- N06DA02 donepezil 15 medicines
- N06DA03 rivastigmine 80 medicines
- N06DA04 galantamine 33 medicines
-
N06DA Anticholinesterase anti-dementia drugs 128 medicines
- N06D Anti-dementia drugs 193 medicines
- N06 Psychoanaleptics 766 medicines
4 more subgroups have no medicine with a leaflet on this site.
Medicines in the group and its subgroups
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group N06DA
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
